Brown Derek F J, Edwards David I, Hawkey Peter M, Morrison Donald, Ridgway Geoffrey L, Towner Kevin J, Wren Michael W D
Health Protection Agency, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QW, UK.
J Antimicrob Chemother. 2005 Dec;56(6):1000-18. doi: 10.1093/jac/dki372. Epub 2005 Nov 17.
These evidence-based guidelines have been produced after a literature review of the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). We have considered the detection of MRSA in screening samples and the detection of reduced susceptibility to glycopeptides in S. aureus. Recommendations are given for the identification of S. aureus and for suitable methods of susceptibility testing and screening for MRSA and for S. aureus with reduced susceptibility to glycopeptides. These guidelines indicate what tests should be used but not when the tests are applicable, as aspects of this are dealt with in guidelines on control of MRSA. There are currently several developments in screening media and molecular methods. It is likely that some of our recommendations will require modification as the new methods become available.
这些循证指南是在对耐甲氧西林金黄色葡萄球菌(MRSA)的实验室诊断和药敏试验进行文献综述后制定的。我们考虑了筛查样本中MRSA的检测以及金黄色葡萄球菌对糖肽类药物敏感性降低的检测。针对金黄色葡萄球菌的鉴定、MRSA和对糖肽类药物敏感性降低的金黄色葡萄球菌的合适药敏试验及筛查方法给出了建议。这些指南指出了应使用哪些检测方法,但未提及检测的适用时机,因为MRSA控制指南中已涉及这方面内容。目前筛查培养基和分子方法有多项进展。随着新方法的出现,我们的一些建议可能需要修改。